Preclinical research suggests it remains effective even at very low doses, with no significant toxicity observed in animal studies
Efectos secundarios frecuentes (pueden afectar hasta a 1 de cada 10 personas): Reaccin de hipersensibilidad (como una erupcin cutnea)
For someone weighing 220 pounds, that represents a potential loss of 33 or more pounds under proper medical supervision
Before starting GLP-1 medications: Ensure you've had a recent diabetic eye screening (within the past 12 months) Discuss your retinopathy status with your prescribing clinician If you have known retinopathy, consider ophthalmology review before initiation Understand that gradual dose titration may help avoid very rapid changes in blood glucose, which is a general principle in diabetes management During treatment: Attend all scheduled diabetic eye screening appointments without fail If you have pre-existing retinopathy, your diabetes team may consider more frequent monitoring based on your individual clinical situation Control blood pressure to target levels (below 140/90 mmHg, or below 130/80 mmHg if you have kidney, eye or cerebrovascular damage, if tolerated) [13] Maintain good overall glycaemic control whilst avoiding excessively rapid HbA1c reductions when possible Stop smoking if applicable, as tobacco significantly worsens diabetic eye disease Manage cholesterol levels according to NICE guidance for cardiovascular risk reduction Communicate openly with your healthcare team about any visual symptoms, even if they seem minor
While GLP-1 slows the stomach, the combined hormonal signal acts directly on the brains reward centers to dampen dopamine food reward cravings
